OBJECTIVES: This paper reviews the neurobiology of bipolar disorder (BD), particularly findings associated with impaired cellular resilience and plasticity. METHODS: PubMed/Medline articles and book chapters published over the last 20 years were identified using the following keyword combinations: BD, calcium, cytokines, endoplasmic reticulum (ER), genetics, glucocorticoids, glutamate, imaging, ketamine, lithium, mania, mitochondria, neuroplasticity, neuroprotection, neurotrophic, oxidative stress, plasticity, resilience, and valproate. RESULTS: BD is associated with impaired cellular resilience and synaptic dysfunction at multiple levels, associated with impaired cellular resilience and plasticity. These findings were partially prevented or even reversed with the use of mood stabilizers, but longitudinal studies associated with clinical outcome remain scarce. CONCLUSIONS: Evidence consistently suggests that BD involves impaired neural plasticity and cellular resilience at multiple levels. This includes the genetic and intra- and intercellular signalling levels, their impact on brain structure and function, as well as the final translation into behaviour/cognitive changes. Future studies are expected to adopt integrated translational approaches using a variety of methods (e.g., microarray approaches, neuroimaging, genetics, electrophysiology, and the new generation of -omics techniques). These studies will likely focus on more precise diagnoses and a personalized medicine paradigm in order to develop better treatments for those who need them most.
OBJECTIVES: This paper reviews the neurobiology of bipolar disorder (BD), particularly findings associated with impaired cellular resilience and plasticity. METHODS: PubMed/Medline articles and book chapters published over the last 20 years were identified using the following keyword combinations: BD, calcium, cytokines, endoplasmic reticulum (ER), genetics, glucocorticoids, glutamate, imaging, ketamine, lithium, mania, mitochondria, neuroplasticity, neuroprotection, neurotrophic, oxidative stress, plasticity, resilience, and valproate. RESULTS: BD is associated with impaired cellular resilience and synaptic dysfunction at multiple levels, associated with impaired cellular resilience and plasticity. These findings were partially prevented or even reversed with the use of mood stabilizers, but longitudinal studies associated with clinical outcome remain scarce. CONCLUSIONS: Evidence consistently suggests that BD involves impaired neural plasticity and cellular resilience at multiple levels. This includes the genetic and intra- and intercellular signalling levels, their impact on brain structure and function, as well as the final translation into behaviour/cognitive changes. Future studies are expected to adopt integrated translational approaches using a variety of methods (e.g., microarray approaches, neuroimaging, genetics, electrophysiology, and the new generation of -omics techniques). These studies will likely focus on more precise diagnoses and a personalized medicine paradigm in order to develop better treatments for those who need them most.
Authors: Heike Weber; Sarah Kittel-Schneider; Alexandra Gessner; Katharina Domschke; Maria Neuner; Christian P Jacob; Henriette N Buttenschon; Andrea Boreatti-Hümmer; Julia Volkert; Sabine Herterich; Bernhard T Baune; Silke Gross-Lesch; Juliane Kopf; Susanne Kreiker; Thuy Trang Nguyen; Lena Weissflog; Volker Arolt; Ole Mors; Jürgen Deckert; Klaus-Peter Lesch; Andreas Reif Journal: Neuropsychopharmacology Date: 2011-06-08 Impact factor: 7.853
Authors: Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw Journal: Arch Gen Psychiatry Date: 2004-05
Authors: Rafael T de Sousa; Emilio L Streck; Orestes V Forlenza; Andre R Brunoni; Marcus V Zanetti; Gabriela K Ferreira; Breno S Diniz; Luis V Portela; André F Carvalho; Carlos A Zarate; Wagner F Gattaz; Rodrigo Machado-Vieira Journal: Neurosci Lett Date: 2015-08-20 Impact factor: 3.046
Authors: Rodrigo Machado-Vieira; Marcus V Zanetti; Antonio L Teixeira; Miyuki Uno; Leandro L Valiengo; Marcio G Soeiro-de-Souza; Sueli M Oba-Shinjo; Rafael T de Sousa; Carlos A Zarate; Wagner F Gattaz; Suely K N Marie Journal: Eur Neuropsychopharmacol Date: 2015-02-16 Impact factor: 4.600
Authors: Rafael T de Sousa; Carlos A Zarate; Marcus V Zanetti; Alana C Costa; Leda L Talib; Wagner F Gattaz; Rodrigo Machado-Vieira Journal: J Psychiatr Res Date: 2013-12-06 Impact factor: 4.791
Authors: Rodrigo Machado-Vieira; Marcus V Zanetti; Maria C Otaduy; Rafael T De Sousa; Marcio G Soeiro-de-Souza; Alana C Costa; Andre F Carvalho; Claudia C Leite; Geraldo F Busatto; Carlos A Zarate; Wagner F Gattaz Journal: J Clin Psychopharmacol Date: 2017-02 Impact factor: 3.153
Authors: Antonio L Teixeira; Rafael Teixeira de Sousa; Rafael T de Souza; Marcus V Zanetti; Andre R Brunoni; Geraldo F Busatto; Carlos A Zarate; Wagner F Gattaz; Rodrigo Machado-Vieira Journal: Hum Psychopharmacol Date: 2015-01 Impact factor: 1.672
Authors: Rafael T de Sousa; Emilio L Streck; Marcus V Zanetti; Gabriela K Ferreira; Breno S Diniz; Andre R Brunoni; Geraldo F Busatto; Wagner F Gattaz; Rodrigo Machado-Vieira Journal: Psychopharmacology (Berl) Date: 2014-06-26 Impact factor: 4.530